Skip to main content
Erschienen in: Clinical Research in Cardiology 7/2016

17.12.2015 | Original Paper

Applicability of next generation balloon-expandable transcatheter heart valves in aortic annuli exceeding formally approved dimensions

verfasst von: Andreas Schaefer, Matthias Linder, Hendrik Treede, Florian Deuschl, Niklas Schofer, Moritz Seiffert, Yvonne Schneeberger, Stefan Blankenberg, Hermann Reichenspurner, Ulrich Schaefer, Lenard Conradi

Erschienen in: Clinical Research in Cardiology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Physicians are frequently confronted with patients suffering from aortic stenosis with annular diameters exceeding dimensions in which currently available transcatheter heart valves (THV) are formally approved. Experience in patients receiving significantly undersized Sapien 3 (S3) THV (Edwards Lifesciences, Inc., Irvine, CA, USA) in aortic annuli up to 32 mm has not been reported so far.

Methods

Patients with aortic annuli exceeding the formally determined upper size limit and who received a 29 mm S3, were identified from our database. Calcification pattern and annulus dimension were analyzed retrospectively using the 3mensio Medical Imaging software. Clinical endpoints were adjudicated in accordance with the updated standardized VARC-2 definitions.

Results

21 consecutive patients with aortic annuli ≥28.1 mm received a 29 mm THV. All patients were male (77.4 ± 8.1 year, logEuroSCORE I 22.5 ± 14.1 %). Multi-slice computed tomography and transesophageal echocardiography derived annular dimensions were 30.2 ± 1.5 vs. 28.8 ± 0.9 mm (p = 0.0001). Total calcium load of the aortic valves was 1327 ± 957 mm3. Device success according to VARC-2 definitions was achieved in 100 % (21/21). All-cause 30-day mortality was 0 % (0/21). Rate of permanent pacemaker implantation was 14.3 % (3/21). No paravalvular leakage ≥ grade II was detectable.

Conclusions

Preliminary experience suggests implantation of this type of THV in aortic annuli up to 32 mm to be feasible and safe, in particular calcification patterns. It does not result in a relevant incidence of PVL ≥ grade II, or increased rate of VARC-2 adjudicated clinical endpoints. Also, functional outcomes regarding transvalvular gradients or EOA demonstrate applicability of this THV in such patients.
Literatur
1.
Zurück zum Zitat Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198CrossRefPubMed Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198CrossRefPubMed
2.
Zurück zum Zitat Makkar RR, Fontana GP, Jilaihawi H et al (2012) Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366(18):1696–1704CrossRefPubMed Makkar RR, Fontana GP, Jilaihawi H et al (2012) Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366(18):1696–1704CrossRefPubMed
3.
Zurück zum Zitat Vahanian A, Alfieri O, Andreotti F et al ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version (2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012(42):S1–S44 Vahanian A, Alfieri O, Andreotti F et al ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version (2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012(42):S1–S44
4.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO et al (2014) 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):2438–2488CrossRefPubMed Nishimura RA, Otto CM, Bonow RO et al (2014) 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):2438–2488CrossRefPubMed
5.
Zurück zum Zitat Holzamer A, Sitka E, Hengstenberg C et al (2015) Multislice computed tomography-based prediction of the implantation plane in transcatheter aortic valve implantation: determination of the line of perpendicularity and the implanter’s views. Eur J Cardiothorac Surg 48(6):879–886CrossRefPubMed Holzamer A, Sitka E, Hengstenberg C et al (2015) Multislice computed tomography-based prediction of the implantation plane in transcatheter aortic valve implantation: determination of the line of perpendicularity and the implanter’s views. Eur J Cardiothorac Surg 48(6):879–886CrossRefPubMed
6.
Zurück zum Zitat Schmidkonz C, Marwan M, Klinghammer L et al (2014) Interobserver variability of CT angiography for evaluation of aortic annulus dimensions prior to transcatheter aortic valve implantation (TAVI). Eur J Radiol 83(9):1672–1678CrossRefPubMed Schmidkonz C, Marwan M, Klinghammer L et al (2014) Interobserver variability of CT angiography for evaluation of aortic annulus dimensions prior to transcatheter aortic valve implantation (TAVI). Eur J Radiol 83(9):1672–1678CrossRefPubMed
7.
Zurück zum Zitat Staubach S, Franke J, Gerckens U et al (2013) Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv 81(2):348–355CrossRefPubMed Staubach S, Franke J, Gerckens U et al (2013) Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv 81(2):348–355CrossRefPubMed
8.
Zurück zum Zitat Husser O, Holzamer A, Resch M et al (2013) Prosthesis sizing for transcatheter aortic valve implantation—comparison of three dimensional transesophageal echocardiography with multislice computed tomography. Int J Cardiol 168(4):3431–3438CrossRefPubMed Husser O, Holzamer A, Resch M et al (2013) Prosthesis sizing for transcatheter aortic valve implantation—comparison of three dimensional transesophageal echocardiography with multislice computed tomography. Int J Cardiol 168(4):3431–3438CrossRefPubMed
9.
Zurück zum Zitat Leber AW, Eichinger W, Rieber J et al (2013) MSCT guided sizing of the Edwards Sapien XT TAVI device: impact of different degrees of oversizing on clinical outcome. Int J Cardiol 168(3):2658–2664CrossRefPubMed Leber AW, Eichinger W, Rieber J et al (2013) MSCT guided sizing of the Edwards Sapien XT TAVI device: impact of different degrees of oversizing on clinical outcome. Int J Cardiol 168(3):2658–2664CrossRefPubMed
10.
Zurück zum Zitat Mylotte D, Andalib A, Thériault-Lauzier P et al (2015) Transcatheter heart valve failure: a systematic review. Eur Heart J 36(21):1306–1327CrossRefPubMed Mylotte D, Andalib A, Thériault-Lauzier P et al (2015) Transcatheter heart valve failure: a systematic review. Eur Heart J 36(21):1306–1327CrossRefPubMed
11.
Zurück zum Zitat Schymik G, Schröfel H, Heimeshoff M et al (2015) How to adapt the implantation technique for the new SAPIEN 3 transcatheter heart valve design. J Interv Cardiol 28(1):82–89CrossRefPubMed Schymik G, Schröfel H, Heimeshoff M et al (2015) How to adapt the implantation technique for the new SAPIEN 3 transcatheter heart valve design. J Interv Cardiol 28(1):82–89CrossRefPubMed
12.
Zurück zum Zitat Seiffert M, Franzen O, Conradi L et al (2010) Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter Cardiovasc Interv 76:608–615CrossRefPubMed Seiffert M, Franzen O, Conradi L et al (2010) Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter Cardiovasc Interv 76:608–615CrossRefPubMed
13.
Zurück zum Zitat Kappetein AP, Head SJ, Généreux P et al (2012) Valve Academic Research Consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42:S45–S60CrossRefPubMed Kappetein AP, Head SJ, Généreux P et al (2012) Valve Academic Research Consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42:S45–S60CrossRefPubMed
14.
15.
16.
Zurück zum Zitat Yang TH, Webb JG, Blanke P et al (2015) Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. JACC Cardiovasc Interv 8(3):462–471CrossRefPubMed Yang TH, Webb JG, Blanke P et al (2015) Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. JACC Cardiovasc Interv 8(3):462–471CrossRefPubMed
17.
Zurück zum Zitat Koos R, Mahnken AH, Dohmen G et al (2011) Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. Int J Cardiol 150(2):142–145CrossRefPubMed Koos R, Mahnken AH, Dohmen G et al (2011) Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. Int J Cardiol 150(2):142–145CrossRefPubMed
18.
Zurück zum Zitat Haensig M, Rastan AJ (2012) Aortic valve calcium load before TAVI: is it important? Ann Cardiothorac Surg 1(2):160–164PubMedPubMedCentral Haensig M, Rastan AJ (2012) Aortic valve calcium load before TAVI: is it important? Ann Cardiothorac Surg 1(2):160–164PubMedPubMedCentral
19.
Zurück zum Zitat Schymik G, Heimeshoff M, Bramlage P et al (2014) Ruptures of the device landing zone in patients undergoing transcatheter aortic valve implantation: an analysis of TAVI Karlsruhe (TAVIK) patients. Clin Res Cardiol 103(11):912–920CrossRefPubMed Schymik G, Heimeshoff M, Bramlage P et al (2014) Ruptures of the device landing zone in patients undergoing transcatheter aortic valve implantation: an analysis of TAVI Karlsruhe (TAVIK) patients. Clin Res Cardiol 103(11):912–920CrossRefPubMed
20.
Zurück zum Zitat Hayashida K, Bouvier E, Lefèvre T et al (2013) Potential mechanism of annulus rupture during transcatheter aortic valve implantation. Catheter Cardiovasc Interv 82(5):E742–E746CrossRefPubMed Hayashida K, Bouvier E, Lefèvre T et al (2013) Potential mechanism of annulus rupture during transcatheter aortic valve implantation. Catheter Cardiovasc Interv 82(5):E742–E746CrossRefPubMed
Metadaten
Titel
Applicability of next generation balloon-expandable transcatheter heart valves in aortic annuli exceeding formally approved dimensions
verfasst von
Andreas Schaefer
Matthias Linder
Hendrik Treede
Florian Deuschl
Niklas Schofer
Moritz Seiffert
Yvonne Schneeberger
Stefan Blankenberg
Hermann Reichenspurner
Ulrich Schaefer
Lenard Conradi
Publikationsdatum
17.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 7/2016
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-015-0954-9

Weitere Artikel der Ausgabe 7/2016

Clinical Research in Cardiology 7/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.